Leflunomide and Osteoporosis: What You Need to Know
In my latest blog post, I delve into the relationship between Leflunomide, a drug commonly used to treat rheumatoid arthritis, and osteoporosis. I discuss how Leflunomide can potentially lead to bone density loss, thus increasing the risk of osteoporosis. I also cover the importance of regular bone density checks for patients on this medication. Additionally, I suggest some preventative measures and alternatives to Leflunomide to help mitigate these risks. It's a must-read for anyone dealing with arthritis or concerned about their bone health.
0
